Intra-Cellular Therapies Comprehensive Income 2013-2024 | ITCI

Intra-Cellular Therapies comprehensive income for the quarter ending September 30, 2024 was $0.002B, a 222.02% decline year-over-year.

  • Intra-Cellular Therapies comprehensive income for 2023 was $0B, a 102.48% decline from 2022.
  • Intra-Cellular Therapies comprehensive income for 2022 was $-0.004B, a 1051.1% increase from 2021.
  • Intra-Cellular Therapies comprehensive income for 2021 was $-0B, a 175.68% decline from 2020.

Intra-Cellular Therapies Comprehensive Income 2013-2024 | ITCI

  • Intra-Cellular Therapies comprehensive income for 2023 was $0B, a 102.48% decline from 2022.
  • Intra-Cellular Therapies comprehensive income for 2022 was $-0.004B, a 1051.1% increase from 2021.
  • Intra-Cellular Therapies comprehensive income for 2021 was $-0B, a 175.68% decline from 2020.